209 related articles for article (PubMed ID: 9294307)
21. Suplatast tosilate inhibits goblet-cell metaplasia of airway epithelium in sensitized mice.
Shim JJ; Dabbagh K; Takeyama K; Burgel PR; Dao-Pick TP; Ueki IF; Nadel JA
J Allergy Clin Immunol; 2000 Apr; 105(4):739-45. PubMed ID: 10756224
[TBL] [Abstract][Full Text] [Related]
22. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
Yoshida M; Aizawa H; Inoue H; Matsumoto K; Koto H; Komori M; Fukuyama S; Okamoto M; Hara N
J Asthma; 2002 Sep; 39(6):545-52. PubMed ID: 12375715
[TBL] [Abstract][Full Text] [Related]
23. Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma.
Sano Y; Suzuki N; Yamada H; To Y; Ogawa C; Ohta K; Adachi M
J Allergy Clin Immunol; 2003 May; 111(5):958-66. PubMed ID: 12743558
[TBL] [Abstract][Full Text] [Related]
24. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
25. Effects of suplatast tosilate on airway inflammation and airway hyperresponsiveness.
Horiguchi T; Tachikawa S; Handa M; Hanazono K; Kondo R; Ishibashi A; Banno K
J Asthma; 2001 Jun; 38(4):331-6. PubMed ID: 11456386
[TBL] [Abstract][Full Text] [Related]
26. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies.
Furukido K; Takeno S; Ueda T; Hirakawa K; Yajin K
Am J Rhinol; 2002; 16(6):329-36. PubMed ID: 12512908
[TBL] [Abstract][Full Text] [Related]
27. Kimura's disease treated with suplatast tosilate and loratadine.
Ueda T; Arai S; Amoh Y; Katsuoka K
Eur J Dermatol; 2011; 21(6):1020-1. PubMed ID: 21914581
[No Abstract] [Full Text] [Related]
28. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate.
Shirai T; Hashimoto D; Suzuki K; Osawa S; Aonahata M; Chida K; Nakamura H
J Allergy Clin Immunol; 2001 May; 107(5):924-5. PubMed ID: 11344364
[No Abstract] [Full Text] [Related]
29. Successful treatment of pediatric hypereosinophilic syndrome with suplatast tosilate.
Yamada Y; Yoshihara S; Arisaka O
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):380-1. PubMed ID: 17941289
[No Abstract] [Full Text] [Related]
30. Treatment of non-episodic angioedema associated with eosinophilia with suplatast tosilate, an anti-allergic selective Th2 cytokine inhibitor.
Hashizume H; Umayahara T
Eur J Dermatol; 2014; 24(2):250-2. PubMed ID: 24723649
[No Abstract] [Full Text] [Related]
31. Effects of suplatast tosilate, a new type of anti-allergic agent, on airway cough hypersensitivity induced by airway allergy in guinea-pigs.
Myou S; Fujimura M; Kurashima K; Kita T; Tachibana H; Ishiura Y; Abo M; Nakao S
Clin Exp Allergy; 2001 Dec; 31(12):1939-44. PubMed ID: 11737047
[TBL] [Abstract][Full Text] [Related]
32. Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness.
Zhao GD; Yokoyama A; Kohno N; Sakai K; Hamada H; Hiwada K
Int Arch Allergy Immunol; 2000 Feb; 121(2):116-22. PubMed ID: 10705221
[TBL] [Abstract][Full Text] [Related]
33. Pemphigoid nodularis associated with psoriatic erythroderma: successful treatment with suplatast tosilate.
Teraki Y; Fukuda T
Br J Dermatol; 2008 Feb; 158(2):424-6. PubMed ID: 18047503
[No Abstract] [Full Text] [Related]
34. [Chronic eosinophilic pneumonia involving eosinophil cationic protein and bone marrow cells].
Nakamura Y; Hoshino M; Miyasaka T; Shimizu K; Yamashiro Y; Joon J; Sim ; Hosaka K; Uchida K; Fukushima Y; Akasaka Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Oct; 34(10):1115-20. PubMed ID: 8953906
[TBL] [Abstract][Full Text] [Related]
35. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma.
Shioya T; Satake M; Sano M; Kagaya M; Watanabe A; Sato K; Ito T; Ito N; Sasaki M; Miura M
Eur J Clin Pharmacol; 2002 Jun; 58(3):171-6. PubMed ID: 12107601
[TBL] [Abstract][Full Text] [Related]
36. Chronic eosinophilic pneumonia: a case report.
Phunmanee A; Boonsawat W; Charoensiri DJ; Limkunacul C
J Med Assoc Thai; 2000 Aug; 83(8):959-63. PubMed ID: 10998853
[TBL] [Abstract][Full Text] [Related]
37. Suplatast tosilate for treating cutaneous mastocytosis.
Yasudo H; Ando T; Hiwatari M; Oka A
Pediatr Dermatol; 2015; 32(3):e118-9. PubMed ID: 25779849
[TBL] [Abstract][Full Text] [Related]
38. Effect of suplatast tosilate, an antiallergic selective Th2 cytokine inhibitor, on acute eosinophilic myocarditis: a case report.
Umemoto S; Itagaki K; Kimura M; Itoh S; Tanaka M; Haraguchi M; Matsuzaki M
Heart Vessels; 2003 May; 18(2):100-2. PubMed ID: 12756607
[TBL] [Abstract][Full Text] [Related]
39. A case of recurrent cutaneous eosinophilic vasculitis: successful adjuvant therapy with suplatast tosilate.
Sakuma-Oyama Y; Nishibu A; Oyama N; Saito M; Nakamura K; Kaneko F
Br J Dermatol; 2003 Oct; 149(4):901-3. PubMed ID: 14616398
[No Abstract] [Full Text] [Related]
40. Anti-inflammatory effect of suplatast tosilate on mild asthma.
Sano Y; Miyamoto T; Makino S
Chest; 1997 Sep; 112(3):862-3. PubMed ID: 9315837
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
